Shares of Merck & Co. Inc. MRK dropped 0.58% to $114.96 Tuesday, on what proved to be an all-around positive trading session ...

Shares of Merck & Co. Inc. MRK shed 1.31% to $115.63 Monday, on what proved to be an all-around great trading session for the ...

Researchers in Singapore have explored whether Zoom virtual backgrounds contribute to VF and have investigated the factors ...

Gilead Sciences’ capsid inhibitor lenacapavir has the most competitive potential in long-acting combination regimens in HIV, ...

Learn more about AP Buyline here. Virtual credit cards help protect you and your account against fraud when making purchases online, over the phone or through a mobile wallet. Virtual credit cards ...

Merck (NYSE: MRK) is a top pharmaceutical company coming off a good quarter that shows it is growing its top and bottom lines. Even with that growth, the stock still trades at a fairly modest ...

Merck faces significant challenges, including increased competition and regulatory scrutiny for Keytruda. Keytruda is facing potential threats from competitors like Summit Therapeutics ...

Running commands in the background is a powerful feature in Linux that allows users to execute long-running processes without tying up the terminal. This capability is particularly useful for ...

It is hard to get excited after looking at Merck's (NYSE:MRK) recent performance, when its stock has declined 5.6% over the past three months. But if you pay close attention, you might find that ...

A virtual phone number is a special kind of phone number that doesn’t connect to a physical phone. Instead, it works over the internet, so you can use it on different devices, like your computer or ...

Merck is halting the phase 3 KEYNOTE-867 study (NCT03924869) and KEYNOTE-630 study (NCT03833167) of pembrolizumab (Keytruda) due to futility, based on recommendations from an independent data ...

A Merck & Co. effort to move its PD-1 behemoth Keytruda into early treatment of lung cancer has reached a dead end, along with another bid to expand into a type of early-stage skin cancer.